Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: P53 determines the switch by regulating xpc, ddb2,and DNA double-strand breaks
Luís F.Z. Batista, Wynand P. Roos, Markus Christmann, Carlos F.M. Menck, Bernd Kaina
Dive into the research topics of 'Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: P53 determines the switch by regulating xpc, ddb2,and DNA double-strand breaks'. Together they form a unique fingerprint.